These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9584899)

  • 1. Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers.
    Lopes JM; Hannisdal E; Bjerkehagen B; Bruland OS; Danielsen HE; Pettersen EO; Sobrinho-Simões M; Nesland JM
    Anal Cell Pathol; 1998; 16(1):45-62. PubMed ID: 9584899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance.
    Lopes JM; Bruland OS; Bjerkehagen B; Silva MC; Holm R; Pettersen EO; Solheim OP; Sobrinho-Simões M; Nesland JM
    Pathol Res Pract; 1997; 193(1):21-36. PubMed ID: 9112270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma.
    Oda Y; Hashimoto H; Takeshita S; Tsuneyoshi M
    Cancer; 1993 Jul; 72(2):478-85. PubMed ID: 8100481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
    Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
    Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial sarcoma. A DNA flow cytometric study.
    el-Naggar AK; Ayala AG; Abdul-Karim FW; McLemore D; Ballance WW; Garnsey L; Ro JY; Batsakis JG
    Cancer; 1990 May; 65(10):2295-300. PubMed ID: 2161280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotype, proliferation, DNA ploidy, and biological behavior of gastrointestinal stromal tumors: a multivariate clinicopathologic study.
    Rudolph P; Gloeckner K; Parwaresch R; Harms D; Schmidt D
    Hum Pathol; 1998 Aug; 29(8):791-800. PubMed ID: 9712419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of proliferation-related markers, p53, and DNA ploidy for survival in patients with soft tissue spindle-cell sarcomas.
    Golouh R; Bracko M; Novak J
    Mod Pathol; 1996 Sep; 9(9):919-24. PubMed ID: 8878024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.
    Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ
    Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density.
    Mandard AM; Denoux Y; Herlin P; Duigou F; van De Vijver MJ; Clahsen PC; van Den Broek L; Sahmoud TM; Henry-Amar M; van De Velde CJ
    Cancer; 2000 Oct; 89(8):1748-57. PubMed ID: 11042570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma.
    Kawauchi S; Goto Y; Liu XP; Furuya T; Oga A; Oda Y; Tsuneyoshi M; Ihara K; Sasaki K
    Cancer; 2001 Mar; 91(5):1005-12. PubMed ID: 11251953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas.
    Choi HJ; Jung IK; Kim SS; Hong SH
    Dis Colon Rectum; 1997 Jan; 40(1):51-9. PubMed ID: 9102262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.
    Keshgegian AA; Cnaan A
    Am J Clin Pathol; 1995 Jul; 104(1):42-9. PubMed ID: 7611179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular schwannoma. A clinicopathologic, DNA flow cytometric, and proliferation marker study of 70 patients.
    Casadei GP; Scheithauer BW; Hirose T; Manfrini M; Van Houton C; Wood MB
    Cancer; 1995 Mar; 75(5):1109-19. PubMed ID: 7850709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables.
    Pelosi G; Bresaola E; Bogina G; Pasini F; Rodella S; Castelli P; Iacono C; Serio G; Zamboni G
    Hum Pathol; 1996 Nov; 27(11):1124-34. PubMed ID: 8912819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
    ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma.
    Hasegawa T; Yokoyama R; Matsuno Y; Shimoda T; Hirohashi S
    Hum Pathol; 2001 Mar; 32(3):257-63. PubMed ID: 11274633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
    Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
    Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
    Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
    Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic role of molecular markers in 99 KIT-positive gastric stromal tumors in Taiwanese.
    Hu TH; Chuah SK; Lin JW; Chiu YC; Changchien CS; Wang CC; Chen YS; Yi LN; Chiu KW; Lee CM
    World J Gastroenterol; 2006 Jan; 12(4):595-602. PubMed ID: 16489674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.